Company / Current Liabilities per Share
Haemonetics Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$11.38
FY2025
5-year range
$4.90 / $11.38
FY2021-FY2025
Trend
+91.2%
vs FY2024
Sector context
#42 of 163
Health Care
What the data says
At $11.38, Haemonetics's current liabilities per share ranks #122 of 163 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $3.59 in FY2016 to $11.38 in FY2025.
Based on SEC 10-K filings.
11.38 in FY2025 with a 5-year CAGR of +16.3%.
Increased from $4.90 to $11.38 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +9.8%
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- -
Sector benchmark
#122 of 163 in Health CareTop 74% of 163This company $11.38 Sector average $28.65
▼
-60.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 91.2% year-over-year.
- Ranks #42 out of 163 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.38 | +91.2% |
| FY2024 | $5.95 | +21.5% |
| FY2023 | $4.90 | -43.0% |
| FY2022 | $8.60 | +74.2% |
| FY2021 | $4.94 | -7.9% |
| FY2020 | $5.36 | +17.8% |
| FY2019 | $4.55 | -38.2% |
| FY2018 | $7.36 | +77.6% |
| FY2017 | $4.15 | +15.5% |
| FY2016 | $3.59 | -1.0% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026